Table 1.
Demographic and clinical characteristics.
| MIG w RLS (n = 22) | MIG w/o RLS (n = 22) | CRL (n = 19) | p-Value | |
|---|---|---|---|---|
| Age | 33.0 ± 9.0 | 32.4 ± 7.7 | 33.5 ± 9.1 | 0.92 |
| Sex (male/female) | 2/20 | 3/19 | 2/17 | 0.89 |
| Aura/no aura | 11/11 | 11/11 | / | / |
| Mean migraine duration (years) | 14.5 ± 10.8 | 11.9 ± 7.4 | / | 0.38 |
| Mean migraine frequency (days/month) | 7.8 ± 6.3 | 6.1 ± 5.8 | / | 0.42 |
| Mean RLS duration (months) | 49.8 ± 44.1 | / | / | / |
| Mean IRLSSG severity score (0–40) | 10.6 ± 8.5 | / | / | / |
| Mean PSQI total score (0–21) | 10.5 ± 4.0 | 7.9 ± 3.1 | / | 0.02 |
| Mean HADS score (0–42) | 13.7 ± 6.0 | 12.5 ± 7.1 | / | 0.56 |
| Mean BDI score (0–63) | 9.1 ± 5.3 | 8.4 ± 5.9 | / | 0.67 |
| Frame displacement (mm) | 0.08 ± 0.04 | 0.07 ± 0.03 | 0.08 ± 0.02 | 0.88 |
BDI, Beck Depression Inventory; CRL, healthy controls; HADS, Hospital Anxiety and Depression Scale; IRLSSG, International Restless Legs Syndrome Study Group; MIG w/o RLS, migraine without restless legs syndrome; MIG w RLS, migraine with restless legs syndrome; PSQI, Pittsburgh Sleep Quality Index.